Reduced CD4+ subset and Th1 bias of the human iNKT cells in Type 1 diabetes mellitus

Journal of Leukocyte Biology

Volumn 81, Issue 3, 2007, Pages 654-662

  Kis, Janos ^a,c   Engelmann, Peter ^a,d   Farkas, Klara ^a,e   Richman, Geoffrey ^a   Eck, Shawn ^a   Lolley, James ^a   Jalahej, Heyam ^a   Borowiec, Maciej ^a   Kent, Sally C ^b   Treszl, Andras ^a   Orban, Tihamer ^a,f  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c University of Pecs ^*  (Hungary)

^d UNIVERSITY OF PÉCS   (Hungary)

^e BAJCSY ZSILINSZKY HOSPITAL   (Hungary)

^f JOSLIN DIABETES CENTER   (United States)

Author keywords

Autoimmunity; Cytokines; V 24+6B11+ cells

Indexed keywords

CD161 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; FLUORESCEIN ISOTHIOCYANATE; GAMMA INTERFERON; INTERLEUKIN 4; T LYMPHOCYTE RECEPTOR;

ADULT; ANTIGEN EXPRESSION; ARTICLE; AUTOIMMUNE DISEASE; CD4+ T LYMPHOCYTE; CELL FUNCTION; CELL MATURATION; CELL POPULATION; CELL SELECTION; CELL STIMULATION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE COURSE; FEMALE; HUMAN; HUMAN CELL; INSULIN DEPENDENT DIABETES MELLITUS; MALE; NATURAL KILLER CELL; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN DETERMINATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ISOLATION; STATISTICAL ANALYSIS; TH1 CELL;

ADULT; ANTIGENS, CD4; ANTIGENS, CD8; ANTIGENS, SURFACE; CD4-POSITIVE T-LYMPHOCYTES; CELL COUNT; CELLS, CULTURED; CLONE CELLS; DIABETES MELLITUS, TYPE 1; FEMALE; HUMANS; INTERFERON TYPE II; INTERLEUKIN-4; KILLER CELLS, NATURAL; LECTINS, C-TYPE; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; RECEPTORS, ANTIGEN, T-CELL; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TH1 CELLS;

EID: 33847768664     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1189/jlb.1106654     Document Type: Article

References (36)

1. Godfrey, D. I., MacDonald, H. R., Kronenberg, M., Smyth, M. J., Van Kaer, L. (2004) NKT cells: what's in a name? Nat. Rev. Immunol. 4, 231-237.
2. Hammond, K. J., Pelikan, S. B., Crowe, N. Y., Randle-Barrett, E., Nakayama, T., Taniguchi, M., Smyth, M. J., van Driel, I. L., Scollay, R., Baxter, A. G., Godfrey, D. I. (1999) NKT cells are phenotypically and functionally diverse. Eur. J. Immunol. 29, 3768-3781.
3. Gumperz, J. E., Roy, C., Makowska, A., Lum, D., Sugita, M., Podrebarac, T., Koezuka, Y., Porcelli, S. A., Cardell, S., Brenner, M. B., Behar, S. M. (2000) Murine CD1d-restricted T cell recognition of cellular lipids. Immunity 12, 211-221.
4. Zhou, D., Mattner, J., Cantu III, C., Schrantz, N., Yin, N., Gao, Y., Sagiv, Y., Hudspeth, K., Wu, Y. P., Yamashita, T., Teneberg, S., Wang, D., Proia, R. L., Levery, S. B., Savage, P. B., Teyton, L., Bendelac, A. (2004) Lysosomal glycosphingolipid recognition by NKT cells. Science 306, 1786-1789.
5. Van der Vliet, H. J., Molling, J. W., von Blomberg, B. M., Nishi, N., Kolgen, W., van den Eertwegh, A. J., Pinedo, H. M., Giaccone, G., Scheper, R. J. (2004) The immunoregulatory role of CD1d-restricted natural killer T cells in disease. Clin. Immunol. 112, 8-23.
6. Mercer, J. C., Ragin, M. J., August, A. (2005) Natural killer T cells: rapid responders controlling immunity and disease. Int. J. Biochem. Cell Biol. 37, 1337-1343.
7. Wagner, M. J., Hussain, S., Mehan, M., Verdi, J. M., Delovitch, T. L. (2005) A defect in lineage fate decision during fetal thymic invariant NKT cell development may regulate susceptibility to type 1 diabetes. J. Immunol. 174, 6764-6771.
8. Hammond, K. J., Kronenberg, M. (2003) Natural killer T cells: natural or unnatural regulators of autoimmunity? Curr. Opin. Immunol. 15, 683-689.
9. Chang, D. H., Liu, N., Klimek, V., Hassoun, H., Mazumder, A., Nimer, S. D., Jagannath, S., Dhodapkar, M. V. (2006) Enhancement of ligand-dependent activation of human natural killer T cells by lenalidomide: therapeutic implications. Blood 108, 618-621.
10. Mars, L. T., Novak, J., Liblau, R. S., Lehuen, A. (2004) Therapeutic manipulation of iNKT cells in autoimmunity: modes of action and potential risks. Trends Immunol. 25, 471-476.
11. Egawa, T., Eberl, G., Taniuchi, I., Benlagha, K., Geissmann, F., Hennighausen, L., Bendelac, A., Littman, D. R. (2005) Genetic evidence supporting selection of the Vα14i NKT cell lineage from double-positive thymocyte precursors. Immunity 22, 705-716.
12. Doherty, D. G., Norris, S., Madrigal-Estebas, L., McEntee, G., Traynor, O., Hegarty, J. E., O'Farrelly, C. (1999) The human liver contains multiple populations of NK cells, T cells, and CD3+CD56+ natural T cells with distinct cytotoxic activities and Th1, Th2, and Th0 cytokine secretion patterns. J. Immunol. 163, 2314-2321.
13. Durante-Mangoni, E., Wang, R., Shaulov, A., He, Q., Nasser, I., Afdhal, N., Koziel, M. J., Exley, M. A. (2004) Hepatic CD1d expression in hepatitis C virus infection and recognition by resident proinflammatory CD1d-reactive T cells. J. Immunol. 173, 2159-2166.
14. Exley, M. A., Koziel, M. J. (2004) To be or not to be NKT: natural killer T cells in the liver. Hepatology 40, 1033-1040.
15. Norris, S., Doherty, D. G., Collins, C., McEntee, G., Traynor, O., Hegarty, J. E., O'Farrelly, C. (1999) Natural T cells in the human liver: cytotoxic lymphocytes with dual T cell and natural killer cell phenotype and function are phenotypically heterogenous and include Vα24-JαQ and γδ T cell receptor bearing cells. Hum. Immunol. 60, 20-31.
16. Lee, P. T., Putnam, A., Benlagha, K., Teyton, L., Gottlieb, P. A., Bendelac, A. (2002) Testing the NKT cell hypothesis of human IDDM pathogenesis. J. Clin. Invest. 110, 793-800.
17. Gadola, S. D., Dulphy, N., Salio, M., Cerundolo, V. (2002) Vα24-JαQ-independent, CD1d-restricted recognition of α-galactosylceramide by human CD4(+) and CD8αβ(+) T lymphocytes. J. Immunol. 168, 5514-5520.
18. Exley, M., Porcelli, S., Furman, M., Garcia, J., Balk, S. (1998) CD161 (NKR-P1A) costimulation of CD1d-dependent activation of human T cells expressing invariant V α 24 J α Q T cell receptor α chains. J. Exp. Med. 188, 867-876.
19. Kukreja, A., Maclaren, N. K. (2002) NKT cells and type-1 diabetes and the "hygiene hypothesis" to explain the rising incidence rates. Diabetes Technol. Ther. 4, 323-333.
20. Wilson, S. B., Kent, S. C., Patton, K. T., Orban, T., Jackson, R. A., Exley, M., Porcelli, S., Schatz, D. A., Atkinson, M. A., Balk, S. P., Strominger, J. L., Hafler, D. A. (1998) Extreme Th1 bias of invariant Vα24JαQ T cells in type 1 diabetes. Nature 391, 177-181.
21. Oikawa, Y., Shimada, A., Yamada, S., Motohashi, Y., Nakagawa, Y., Irie, J., Maruyama, T., Saruta, T. (2002) High frequency of vα24(+) vβ11(+) T-cells observed in type 1 diabetes. Diabetes Care 25, 1818-1823.
22. Chatenoud, L. (2002) Do NKT cells control autoimmunity? J. Clin. Invest. 110, 747-748.
23. Kent, S. C., Chen, Y., Clemmings, S. M., Viglietta, V., Kenyon, N. S., Ricordi, C., Hering, B., Hafler, D. A. (2005) Loss of IL-4 secretion from human type 1a diabetic pancreatic draining lymph node NKT cells. J. Immunol. 175, 4458-4464.
24. Exley, M. A., Balk, S. P., Wilson, S. B. (2002) Isolation and functional use of human NK T cells. In Current Protocols in Immunology (J. E. Coligan, B.E. Bierer, D.H. Margulies, E. M. Schevach, W. Strober, eds.), Hoboken, NJ, USA, John Wiley & Sons.
25. Tahir, S. M., Cheng, O., Shaulov, A., Koezuka, Y., Bubley, G. J., Wilson, S. B., Balk, S. P., Exley, M. A. (2001) Loss of IFN-γ production by invariant NK T cells in advanced cancer. J. Immunol. 167, 4046-4050.
26. Grubin, C. E., Daniels, T., Toivola, B., Landin-Olsson, M., Hagopian, W. A., Li, L., Karlsen, A. E., Boel, E., Michelsen, B., Lernmark, A. (1994) A novel radioligand binding assay to determine diagnostic accuracy of isoform-specific glutamic acid decarboxylase antibodies in childhood IDDM. Diabetologia 37, 344-350.
27. Christie, M. R., Hollands, J. A., Brown, T. J., Michelsen, B. K., Delovitch, T. L. (1993) Detection of pancreatic islet 64,000 M(r) autoantigens in insulin-dependent diabetes distinct from glutamate decarboxylase. J. Clin. Invest. 92, 240-248.
28. Vardi, P., Dib, S. A., Tuttleman, M., Connelly, J. E., Grinbergs, M., Rabizadeh, A., Riley, W. J., Maclaren, N. K., Eisenbarth, G. S., Soeldner, J. S. (1987) Competitive insulin autoantibody RIA: prospective evaluation of subjects at high risk for development of type I diabetes mellitus. Diabetes 36, 1286-1291.
29. Porcelli, S., Yockey, C. E., Brenner, M. B., Balk, S. P. (1993) Analysis of T cell antigen receptor (TCR) expression by human peripheral blood CD4-8- α/β T cells demonstrates preferential use of several V β genes and an invariant TCR α chain. J. Exp. Med. 178, 1-16.
30. Porcelli, S., Gerdes, D., Fertig, A. M., Balk, S. P. (1996) Human T cells expressing an invariant V α 24-J α Q TCR α are CD4- and heterogeneous with respect to TCR β expression. Hum. Immunol. 48, 63-67.
31. Godfrey, D. I., Hammond, K. J., Poulton, L. D., Smyth, M. J., Baxter, A. G. (2000) NKT cells: facts, functions and fallacies. Immunol. Today 21, 573-583.
32. Sidobre, S., Kronenberg, M. (2002) CD1 tetramers: a powerful tool for the analysis of glycolipid-reactive T cells. J. Immunol. Methods 268, 107-121.
33. Mittag, A., Lenz, D., Gerstner, A. O., Sack, U., Steinbrecher, M., Koksch, M., Raffael, A., Bocsi, J., Tarnok, A. (2005) Polychromatic (eight-color) slide-based cytometry for the phenotyping of leukocyte, NK, and NKT subsets. Cytometry A 65, 103-115.
34. Takahashi, T., Chiba, S., Nieda, M., Azuma, T., Ishihara, S., Shibata, Y., Juji, T., Hirai, H. (2002) Cutting edge: analysis of human V α 24+CD8+ NK T cells activated by α-galactosylceramide-pulsed monocyte-derived dendritic cells. J. Immunol. 168, 3140-3144.
35. Gumperz, J. E., Miyake, S., Yamamura, T., Brenner, M. B. (2002) Functionally distinct subsets of CD1d-restricted natural killer T cells revealed by CD1d tetramer staining. J. Exp. Med. 195, 625-636.
36. Szatmari, I., Gogolak, P., Im, J. S., Dezso, B., Rajnavolgyi, E., Nagy, L. (2004) Activation of PPARγ specifies a dendritic cell subtype capable of enhanced induction of iNKT cell expansion. Immunity 21, 95-106.